The Depo-Provera Litigation (MDL 3140) dominated yesterday's docket with 55 of 104 total filings tracked, as the newly consolidated meningioma litigation accelerates against Pfizer. OnderLaw LLC led the charge with 22 individual filings, followed by Weitz & Luxenberg PC (9) and Nigh Goldenberg Raso Vaughn PLLC (7), signaling a coordinated high-volume prosecution strategy as the docket moves toward resolution of Pfizer's pending preemption motion. Elsewhere, the Johnson & Johnson Talcum Powder Litigation (MDL 2738) added 12 new claims, including 3 each from Heninger Garrison Davis and Wagstaff Law Firm, while the Hair Relaxer Litigation (MDL 3060) saw 8 new cases with Keller Postman LLC submitting 7.
A California state court judge vacated a $950 million verdict against Johnson & Johnson in a talc case on March 17, finding insufficient proof to support the massive award — a rare judicial intervention that reverses one of the largest individual talc verdicts in the litigation's history. The ruling gives J&J a significant defensive win as it faces over 67,000 federal claims in MDL 2738 and prepares for renewed MDL activity following the collapse of its third bankruptcy attempt through Red River Talc LLC. The vacated verdict removes a key benchmark for plaintiff settlement demands and may dampen momentum for high-nine-figure awards in upcoming bellwether selections.
Sexual assault and human trafficking dockets remain highly active, with the Uber Passenger Sexual Assault Litigation (MDL 3084) logging 8 new suits — Cutter Law PC and Levin Simes each filing 3. The lodging industry continues to face scrutiny over trafficking protocols: The Byrd Law Firm and Douglas & London filed in the G6 Hospitality Sex Trafficking Litigation, while The Stoddard Firm brought a new claim in the Khamlai Lodging Sex Trafficking Litigation and Hite Law Firm with Bobby Jones Law initiated a suit in the Whetstone Academy Sex Abuse Litigation. On the emerging litigation watch list, the recently consolidated GLP-1 NAION Litigation (MDL 3163) added 2 new filings from Verhine & Verhine.
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
